Answers are grounded in this paper and cite their sources.
We observed an alarmingly high rate (5/16 patients; 31.3%) of orointestinal colonization with Candida glabrata--often in high numbers--in pediatric bone marrow transplant recipients receiving fluconazole as antifungal prophylaxis. This selection is probably due to the intrinsically low susceptibility of C. glabrata to fluconazole.
No takes yet. Share an insight, caveat, or question.
Hoppe et al. (1994) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: